Amicus Therapeutics' Series C Round

Amicus Therapeutics raised a round of funding on September 22, 2005.

Amicus (NASDQ:FOLD) is a biopharmaceutical company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases.…

Articles about Amicus Therapeutics' Series C Round: